Heart Disease clinical trials at UC Davis

3 in progress, 0 open to eligible people

Showing trials for

  • EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis

    Sorry, in progress, not accepting new patients

    This study will evaluate the safety and effectiveness of the Edwards SAPIEN 3/SAPIEN 3 Ultra Transcatheter Heart Valve (THV) compared with clinical surveillance (CS) in asymptomatic patients with severe, calcific aortic stenosis.

    Sacramento, California and other locations

  • Reduction of Elimination of Mitral Regurgitation With the SATURN TMVR System (CASSINI-US)

    Sorry, not yet accepting patients

    CASSINI-US is a prospective, single-arm, multicenter early feasibility study enrolling up to 15 patients at up to 5 sites in the United States (US). The purpose of the study is to evaluate the technical (implant) feasibility, and safety, and performance of the SATURN TS TMVR System for the treatment of moderate-severe or severe, symptomatic mitral regurgitation through a transcatheter approach. Primary objectives evaluate the implant feasibility, and acute safety and performance of the SATURN TS TMVR System. The secondary objective and additional outcome measures characterize the long-term safety and performance of the SATURN TS TMVR System.

    Sacramento, California and other locations

  • Cardiovascular Health Study (CHS)

    Sorry, in progress, not accepting new patients

    To determine the extent to which known risk factors predict coronary heart disease and stroke in the elderly, to assess the precipitants of coronary heart disease and stroke in the elderly, and to identify the predictors of mortality and functional impairments in clinical coronary disease or stroke.

    Sacramento, California and other locations

Our lead scientists for Heart Disease research studies include .

Last updated: